In esophageal cancer, it inhibits tumor growth by regulating apoptosis and the NF-κB signaling pathway, increasing radiosensitivity, increasing the expression of cleaved caspase 3 and Bax, and decreasing Bcl-2 and NF-κB levels in vitro [29]. The gene discussed is CASP3; the disease is neoplasm.